Table 1.
Patient characteristics and results.
| CS Invasion (+) | CS Invasion (−) | p Value | |
|---|---|---|---|
| Number | 17 | 10 | - |
| Age (years old) | 66.06 (37–85) | 49.45 (32–76) | 0.0030 |
| Sex | Male: 6, Female: 11 | Male: 5, Female: 5 | 0.45 |
| Cystic formation | 6 | 3 | 0.78 |
| Hemorrhagic component | 2 | 1 | 0.89 |
| Tumor volume (cm3) | 27.75 ± 22.33 | 7.16 ± 7.23 | 0.0011 |
| Ki-67 index | <1%: 17 | <1%: 10 | - |
| Mitotic count | 0/10HPF: 13 1/10HPF: 3 2/10HPF: 1 |
0/10HPF: 9 1/10HPF: 1 |
0.38 |
| p53 IHC positive | 0 | 0 | - |
| VEGF-A expression | ++: 6 + or −: 11 |
++: 0 + or −: 10 |
0.033 |
| VEGFR1 expression | +: 12 −: 5 |
+: 3 −: 7 |
0.040 |
| CD163 expression |
7.70 ± 10.9 | 2.60 ± 3.53 | 0.046 |
CS: cavernous sinus, IHC: immunohistochemistry, VEGF: vascular endothelial growth factor, VEGFR: vascular endothelial growth factor receptor.